Qualitative nucleic acid amplification testing for parvovirus B19. For plasma and serum specimens, Parvovirus B19 by Quantitative PCR (2012043) is preferred to establish a diagnosis, differentiate low-level persistence from clinically relevant infection, monitor response to treatment, and predict relapse in immunocompromised hosts.
Qualitative Polymerase Chain Reaction
Mon, Wed, Fri
New York DOH Approval Status
Lavender (EDTA), Pink (K2EDTA), or Serum Separator Tube (SST). Also acceptable: Amniotic fluid, CSF, tissue, paraffin embedded tissue, or synovial fluid.
Separate serum or plasma from cells. Transfer 1 mL serum, plasma, bone marrow, amniotic fluid, CSF, or synovial fluid to a sterile container. (Min: 0.5 mL)
Fresh Tissue: Transfer fresh tissue to a sterile container and freeze immediately.
Paraffin Embedded Tissue: Transport in a Tissue Transport Kit (ARUP supply #47808), available online through eSupply using ARUP Connect or contact
ARUP Client Services at (800) 522-2787.
Bone Marrow: Refrigerated.
Paraffin Embedded Tissue: Room temperature.
Heparinized specimens, tissues in optimal cutting temperature compound.
Specimen source required.
Ambient: 24 hours; Refrigerated: 5 days; Frozen: 6 months
Bone Marrow: Ambient: 1 week; Refrigerated: 1 week; Frozen: 1 week
Fresh Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 6 months
Paraffin Embedded Tissue: Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|0060043||Parvovirus B19 by Qualitative PCR||9572-9|
|2002178||Parvovirus B19 by Qual PCR, Source||31208-2|
- B19 virus PCR
- Fifth Disease-Parvovirus PCR
- Human Parvovirus B19 PCR